| Lactose (India) Ltd | 159 Cr. | 127 | 247/84.3 | 35.3 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.52 Cr. | 1.84 | 4.33/1.82 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,612 Cr. | 423 | 479/192 | 95.5 | 24.3 | 0.16 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 32.0 Cr. | 43.1 | 92.2/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 38.2 Cr. | 26.1 | 29.1/17.0 | 91.1 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 59.6 Cr. | 79.1 | 134/78.1 | 16.1 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 53,015 Cr. | 1,878 | 2,286/1,275 | 21.1 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 350 Cr. | 14.4 | 19.9/10.8 | 21.0 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 5.65 Cr. | 11.7 | 19.2/9.25 | 70.6 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 918 Cr. | 1,945 | 1,971/635 | 31.8 | 334 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 110 Cr. | 22.0 | 32.0/15.6 | 30.0 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 820 Cr. | 279 | 449/219 | 7.32 | 133 | 0.90 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 9.32 Cr. | 3.74 | 9.28/2.11 | 5.29 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 445 Cr. | 458 | 477/121 | 67.2 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,651 Cr. | 1,070 | 1,565/1,038 | 42.1 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 55.2 Cr. | 0.27 | 1.24/0.26 | 3.63 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 37.3 Cr. | 15.5 | 26.3/6.54 | 38.4 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 10.4 Cr. | 10.3 | 17.2/9.00 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 179 Cr. | 503 | 859/443 | 10.2 | 596 | 0.30 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 81.4 Cr. | 81.4 | 92.5/26.1 | 153 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 15,064 Cr. | 1,440 | 2,452/1,345 | 46.8 | 174 | 0.74 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 19.7 Cr. | 43.1 | 88.7/36.1 | 42.8 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 15.8 Cr. | 6.31 | 7.66/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 16.6 Cr. | 110 | 154/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 48.2 Cr. | 88.2 | 88.2/9.41 | 33.3 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 30.1 Cr. | 40.0 | 80.0/37.1 | 48.6 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.30 Cr. | 21.0 | 26.0/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 10,003 Cr. | 578 | 1,028/492 | 28.4 | 72.4 | 0.21 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 86.9 Cr. | 20.1 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.5 Cr. | 22.8 | 43.7/17.4 | 50.2 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 92,435 Cr. | 2,240 | 3,055/2,115 | 55.5 | 376 | 0.04 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 232 Cr. | 403 | 524/241 | 23.8 | 123 | 1.12 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 51.8 Cr. | 36.1 | 62.6/26.7 | 80.9 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 70,927 Cr. | 1,208 | 1,365/994 | 20.7 | 598 | 0.33 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 161 Cr. | 258 | 303/159 | 153 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 800 Cr. | 80.2 | 123/74.0 | 20.7 | 32.6 | 1.87 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 36.8 Cr. | 28.2 | 50.0/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 14,183 Cr. | 1,732 | 1,868/919 | 63.3 | 173 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.49 Cr. | 0.68 | 1.45/0.55 | 112 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 229 Cr. | 29.9 | 68.0/29.6 | 14.7 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 5.65 Cr. | 9.66 | 23.8/9.40 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 137 Cr. | 5.80 | 6.57/2.82 | 318 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 62,762 Cr. | 29,585 | 37,000/25,260 | 41.6 | 1,888 | 1.61 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,459 Cr. | 713 | 972/550 | 26.9 | 226 | 0.70 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 274 Cr. | 94.6 | 100/31.3 | 76.5 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 5,065 Cr. | 1,670 | 1,713/540 | | 104 | 0.06 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 21,533 Cr. | 1,325 | 1,870/1,110 | 392 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 805 Cr. | 230 | 330/154 | 18.7 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 919 Cr. | 689 | 707/270 | 14.5 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,372 Cr. | 478 | 908/438 | 23.2 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,565 Cr. | 1,110 | 1,595/991 | 22.2 | 768 | 0.90 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,25,996 Cr. | 3,721 | 3,882/2,886 | 58.2 | 250 | 0.86 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 1,030 Cr. | 112 | 310/98.0 | | 41.3 | 0.44 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,504 Cr. | 16.0 | 24.0/14.1 | 23.9 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 22,262 Cr. | 582 | 1,360/574 | 64.8 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 4,024 Cr. | 177 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,26,446 Cr. | 1,777 | 1,910/1,547 | 36.9 | 324 | 0.90 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,484 Cr. | 563 | 886/441 | 388 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,658 Cr. | 284 | 329/175 | 32.8 | 81.2 | 0.14 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 416 Cr. | 1,355 | 1,680/956 | 22.2 | 683 | 0.11 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,983 Cr. | 356 | 502/265 | 45.1 | 125 | 0.14 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 6,062 Cr. | 240 | 260/111 | 140 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 10,520 Cr. | 4,569 | 6,718/4,146 | 28.5 | 340 | 2.56 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,675 Cr. | 2,225 | 2,725/1,772 | 33.0 | 335 | 0.90 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,829 Cr. | 5,906 | 6,739/4,904 | 32.0 | 373 | 2.12 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 165 Cr. | 46.7 | 85.0/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 23,007 Cr. | 5,028 | 5,993/3,701 | 32.6 | 841 | 0.70 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 114 Cr. | 92.6 | 348/81.0 | 11.8 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,179 Cr. | 357 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 4,413 Cr. | 870 | 1,998/604 | 84.4 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 21,462 Cr. | 16,719 | 19,748/10,060 | 110 | 1,263 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 316 Cr. | 14.2 | 44.9/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 15,571 Cr. | 869 | 1,505/660 | 10.1 | 483 | 0.69 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,454 Cr. | 44.8 | 91.7/41.7 | 32.5 | 21.8 | 0.45 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,754 Cr. | 193 | 359/162 | 24.9 | 59.3 | 0.41 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 76.2 Cr. | 48.3 | 130/47.2 | | 93.9 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 286 Cr. | 80.2 | 177/78.9 | 140 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 92,771 Cr. | 2,031 | 2,403/1,774 | 21.4 | 430 | 0.59 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,074 Cr. | 533 | 980/490 | 13.4 | 357 | 0.34 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 53,292 Cr. | 987 | 1,034/482 | 78.0 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 990 Cr. | 954 | 1,235/596 | 20.2 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 142 Cr. | 67.3 | 129/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 646 Cr. | 134 | 236/131 | 36.7 | 104 | 2.24 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 634 Cr. | 363 | 500/265 | 23.0 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 17,207 Cr. | 1,080 | 1,265/802 | 34.6 | 414 | 0.46 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 27,365 Cr. | 1,748 | 1,952/1,303 | 38.1 | 243 | 0.89 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,374 Cr. | 206 | 328/193 | 31.4 | 38.0 | 1.21 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 36,523 Cr. | 1,438 | 1,758/1,168 | 36.9 | 293 | 0.28 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,687 Cr. | 91.6 | 127/57.5 | 23.1 | 59.7 | 0.87 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 776 Cr. | 95.3 | 124/67.2 | 26.2 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,304 Cr. | 252 | 355/190 | | 106 | 0.08 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,811 Cr. | 228 | 465/225 | 278 | 96.9 | 0.61 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,450 Cr. | 1,695 | 2,768/1,243 | 33.1 | 397 | 0.41 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,432 Cr. | 343 | 498/285 | 63.2 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,369 Cr. | 551 | 628/412 | 26.2 | 164 | 0.27 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 53,015 Cr. | 1,878 | 2,286/1,275 | 21.1 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 42,513 Cr. | 2,509 | 3,516/1,921 | 44.6 | 101 | 1.67 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 29,907 Cr. | 1,817 | 2,131/1,200 | 25.9 | 610 | 0.99 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,742 Cr. | 414 | 530/359 | 29.9 | 149 | 1.21 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 22,784 Cr. | 1,670 | 1,910/1,097 | 54.8 | 227 | 0.44 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,04,219 Cr. | 1,249 | 1,406/1,020 | 18.1 | 432 | 0.64 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,862 Cr. | 246 | 322/178 | 25.8 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,23,561 Cr. | 1,529 | 1,673/1,310 | 22.7 | 408 | 0.85 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,609 Cr. | 1,920 | 2,641/1,551 | 24.8 | 416 | 0.31 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 309 Cr. | 105 | 203/95.6 | 22.2 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,710 Cr. | 162 | 191/105 | 15.6 | 107 | 0.31 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 63.0 Cr. | 39.0 | 72.0/37.7 | 22.1 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 52,862 Cr. | 395 | 425/291 | 111 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,648 Cr. | 1,633 | 2,190/1,430 | 36.4 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 124 Cr. | 77.7 | 141/76.3 | 18.2 | 49.2 | 1.54 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 395 Cr. | 167 | 205/67.8 | 37.4 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,839 Cr. | 9,134 | 10,691/6,220 | 98.8 | 320 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,025 Cr. | 700 | 843/544 | 35.7 | 118 | 0.66 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 168 Cr. | 79.9 | 137/78.0 | 8.93 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 67,816 Cr. | 5,681 | 5,868/4,492 | 28.8 | 1,116 | 0.79 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 17,650 Cr. | 898 | 1,124/725 | 27.8 | 271 | 1.22 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 460 Cr. | 811 | 1,540/763 | | 690 | 0.61 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 31,335 Cr. | 2,506 | 3,116/2,022 | 32.2 | 345 | 1.12 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,613 Cr. | 323 | 412/258 | 24.5 | 133 | 1.61 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 4,103 Cr. | 447 | 575/312 | 21.5 | 146 | 0.22 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,228.23 Cr | 1,183.75 | | 53.17 | 202.47 | 0.35% | 16.24% | 14.95% | 6.10 |